Clinical Course of Adult Patients With Ependymoma
|
|
- Shanon Arnold
- 5 years ago
- Views:
Transcription
1 Clinical Course of Adult Patients With Ependymoma Results of the Adult Ependymoma Outcomes Project Terri S. Armstrong, PhD 1,2 ; Elizabeth Vera-Bolanos, MS 2 ; and Mark R. Gilbert, MD 2 BACKGROUND: Ependymomas are a rare tumor in adults, and there are limited reports of the clinical course, treatment, and current health status of patients. METHODS: Patients with ependymoma completed an online survey regarding their diagnosis, treatment course, and current health status. Descriptive statistics were used to report the characteristics and degree of symptom severity. Correlations between demographic and clinical characteristics were explored with univariate analysis. RESULTS: One hundred eighteen adults participated, and there were more women (n ¼ 68) than men (n ¼ 50). The median age was 48 years (range, years). Fifty-nine participants (48%) reported that they had not been able to work since their diagnosis, and 31% reported receiving disability benefits. Patients who had been treated for spine tumors had symptoms longer than those who had been treated for brain lesions (chi-square statistic, 7.294; P ¼.026), and the majority had 3 symptoms before diagnosis. Most patients reported undergoing complete resection (brain lesions, 62%; spine tumors, 58%), and patients with spine tumors were less likely to have received additional treatment (chi-square statistic, 9.687; P ¼.008). The majority had not had a recurrence and reported consulting a neurosurgeon for surveillance. Despite having stable disease and not receiving active treatment, most patients described moderate to severe symptoms, including fatigue (44%), numbness/tingling (39%), pain (36%), and disturbed sleep (34%) overall. Brain lesions were associated with altered vision (25%), difficulty concentrating (25%), weakness (19%), irritability (19%), difficulty speaking (19%), and understanding (17%); and spine lesions were associated with extremity weakness (55%), sexual dysfunction (48%), radiating pain (37%), and change in bowel pattern (35%). CONCLUSIONS: Treatment for adult patients with ependymoma is not standardized. Despite the low recurrence rate, patients reported significant symptoms and disability. Cancer 2011;117: VC 2011 American Cancer Society. KEYWORDS: central nervous system, tumor, symptoms, cancer treatment, quality of life. Ependymomas are rare central nervous system (CNS) tumors in adults, comprising 2% to 8% of all primary adult CNS tumors diagnosed in the United States each year. 1 According to the World Health Organization classification system, neoplasms are classified as either very low grade (grade 1 [myxopapillary]), low grade (grade 2), or high grade (grade 3 or anaplastic). Ependymomas can occur throughout the CNS. In adults, ependymomas appear most commonly in the spinal cord and as grade 1 or2 tumors. 2 Although they are less common overall, anaplastic ependymomas (World Health Organization grade 3) tend to occur in the brain and are rare in the spine. The approach to treatment in adults is not standardized; however, patients typically undergo maximal safe tumor resection. Subsequent treatment at initial diagnosis and recurrence with radiation and/or chemotherapy varies based on the extent of resection, the recurrence pattern, and the degree of anaplasia and is reserved for patients who have more malignant anaplastic ependymomas. 3,4 Because of the relative rarity of ependymoma, there are few reports of the pathologic characteristics, tumor location, and clinical course in adult patients, and most include small numbers of patients. 5-8 There are even fewer reports of symptomatology at presentation and the impact of the disease and its treatment on the health status of patients, including those with long-term tumor control Because these tumors are rare and patients often have extended periods of remission, Corresponding author: Terri S. Armstrong, PhD, ANP-BC, FAANP, 6901 Bertner Avenue, Room 791, Houston, TX 77030; Fax: (713) ; terri.s. armstrong@uth.tmc.edu 1 University of Texas Health Science Center-Houston School of Nursing, Houston, Texas; 2 Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. DOI: /cncr.26181, Received: January 7, 2011; Revised: February 22, 2011; Accepted: March 23, 2011, Published online April 28, 2011 in Wiley Online Library (wileyonlinelibrary.com) Cancer November 15,
2 a wide variety of medical disciplines, including neurosurgeons, family practitioners, internists, neurologists, and radiation oncologists, among others, are involved in the treatment and follow-up of these patients. The Ependymoma Outcome (EO) Project was designed by investigators in the Collaborative Ependymoma Research Network (CERN) as an online questionnaire for patients and their caregivers with the goal of gathering information on outcomes for adult patients with ependymoma. The key objectives of the EO Project are to gather information on the treatment strategies and health status of adult patients with ependymoma; to disseminate information to health care providers on the symptoms, treatment, and outcomes of patients with ependymoma with the goal of improving patient management; to publish objective data on trends and regional differences in the care of adult patients who have ependymoma with the goal of improving and standardizing care; and to develop ideas based on these data for future clinical trials with the goal of improving patient survival and outcome. MATERIALS AND METHODS The EO Project opened for enrollment in January 2009 through the CERN Foundation website ( accessed April 11, 2011). The questionnaire can be viewed in its entirety on the CERN Foundation website ( accessed April 11, 2011). Participants initially completed an enrollment form and were then sent a unique participant identification number and were given access to the electronic EO survey. Two groups participated in the survey. The first group consisted of patients with ependymoma or an ependymoma variant who had attended a consultation at The University of Texas MD Anderson Cancer Center in Houston, Texas between 1995 and 2010, and the second group consisted of patients who registered through the website without solicitation. The survey consists of a series of 84 questions related to demographic characteristics, clinical presentation, tumor location, treatments received, and current health status. In addition, the questionnaire includes the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) and the MD Anderson Symptom Inventory-Spine Tumor Module (MDASI-SP), which allow patients to report current symptoms and the interference of symptoms with daily life. The MDASI-BT and MDASI-SP consist of symptoms (23 in the MDASI-BT and 18 in the MDASI-SP) and 6 interference items rated on an 11-point scale from 0 to 10 to indicate the presence and severity of each symptom in the last 24 hours, with 0 indicating not present and 10 indicating as bad as you can imagine. 11,12 The symptoms included on the instrument are those commonly associated with cancer therapies and those symptoms common in the brain and spine tumor patient population. The MDASI-BT has evidence of content and construct validity, discriminant validity by performance status and disease progression, and internal consistency (Cronbach alpha ¼.92). 11 The internal consistency (reliability) of the MDASI-SP is 0.946, and the instrument reportedly was sensitive to disease severity based on Karnofsky performance status (KPS) in a group of patients with both primary and metastatic spinal cord tumors. 12 The statistical analysis was performed using the SPSS software package (version 17.0; SPSS Inc., Chicago, Ill). Descriptive statistics were used to report demographic and clinical characteristics. For symptom data, symptom severity and interference were categorized into clinically meaningful groups based on work by Serlin and colleagues 13 for pain severity cutoff scores and using the methods of Mendoza and colleagues 14 for fatigue severity cutoff scores. We dichotomized mean symptom severity into none/mild (scores from 0 to 3) and moderate/severe (scores from 4 to 10). Correlations between demographic and clinical characteristics were explored with univariate analysis using chi-square tests for categorical variables and independent-sample t tests for continuous variables. RESULTS Participation In total, 118 patients had completed the survey by August 2010 and were included in the current analysis. One hundred thirty-six invitations were sent out to the MD Anderson Cancer Center group, and 59 invited patients (43%) completed the EO survey. One hundred five adults registered without solicitation through the CERN website, and 59 (56%) of those patients completed the survey in that group. Most respondents completed the survey without assistance. Eight patients required help from a family or friend, 10 surveys were completed by a family member, and 1 patient required help from a health care provider to complete the survey. Patient Characteristics Demographic characteristics of the sample are presented in Table 1. Among the participants, there were more 5134 Cancer November 15, 2011
3 EO Project/Armstrong et al Table 1. Demographic Characteristics Characteristic Overall BT ST BT and ST Sex Men 50 (42) 22 (42) 26 (43) 2 (33) Women 68 (58) 30 (58) 34 (57) 4 (67) Current age, y Median Mean Range Age at diagnosis, y Median Mean Range Marital status Never married 16 (14) 11 (21) 4 (7) 1 (17) Married 88 (75) 37 (71) 46 (77) 5 (83) Divorced 7 (6) 0 (0) 7 (12) 0 (0) Widowed 1 (1) 1 (2) 0 (0) 0 (0) Separated 1 (1) 0 (0) 1 (2) 0 (0) NA 5 (4) 3 (6) 2 (3) 0 (0) Education Some high school 2 (2) 2 (4) 0 (0) 0 (0) High school graduate 8 (7) 3 (6) 5 (8) 0 (0) Some college 25 (21) 11 (21) 12 (20) 2 (33) College graduate 40 (34) 20 (39) 20 (33) 0 (0) Postgraduate 39 (33) 14 (27) 21 (35) 4 (67) NA 4 (3) 2 (4) 2 (3) 0 (0) Income <$20,000 5 (4) 4 (8) 1 (2) 0 (0) $20-$59, (22) 11 (21) 14 (23) 0 (0) $60-$99, (17) 12 (23) 6 (10) 2 (33) $100, (39) 17 (33) 25 (42) 4 (67) Prefer not to say 16 (14) 4 (8) 12 (20) 0 (0) NA 6 (5) 4 (8) 2 (3) 0 (0) Currently employed No 60 (51) 31 (60) 28 (47) 1 (17) Full time 42 (36) 15 (29) 24 (40) 3 (50) Part time 9 (8) 3 (6) 4 (7) 2 (33) NA 7 (6) 3 (6) 4 (7) 0 (0) Changed jobs since diagnosis Different job 21 (18) 4 (8) 16 (27) 1 (17) Same job 35 (30) 15 (29) 16 (27) 4 (67) Not working 56 (48) 29 (56) 26 (43) 1 (17) NA 6 (5) 4 (8) 2 (3) 0 (0) Receiving disability benefits No 76 (64) 30 (58) 41 (68) 5 (83) Yes 37 (31) 19 (37) 17 (28) 1 (17) NA 5 (4) 3 (6) 2 (3) 0 (0) Abbreviations: BT, brain tumor; NA, not available; ST, spinal tumor. women (n ¼ 68) than men (n ¼ 50), and the median age at the time the survey was completed was 48 years (range, years). The majority of patients had a college education, and >50% reported a household income $100,000. Sixty patients (51%) were not employed outside the home. Cancer November 15,
4 Table 2. Clinical Characteristics Characteristic Overall BT ST BT and ST Tumor location Brain 52 (44) Spine 60 (51) Brain and spine 6 (5) Tumor type Ependymoma 69 (59) 30 (58) 35 (58) 4 (67) Anaplastic ependymoma 14 (12) 12 (23) 2 (3) 0 (0) Myxopapillary ependymoma 16 (14) 0 (0) 15 (25) 1 (17) Subependymoma 4 (3) 3 (6) 1 (2) 0 (0) Tancytic ependymoma 2 (2) 2 (4) 0 (0) 0 (0) Giant cell ependymoma 2 (2) 0 (0) 1 (2) 1 (17) Did not know name 10 (9) 5 (10) 5 (8) 0 (0) NA 1 (1) 0 (0) 1 (2) 0 (0) Location Brain Left 8 (15) 0 (0) Right 13 (25) 2 (33) Midline 4 (8) 0 (0) NA 30 (58) 4 (67) Supratentorial 16 (31) 0 (0) Infratentorial 27 (52) 5 (83) Both 2 (4) 0 (0) NA 7 (13) 1 (17) Spine Cervical 25 (42) 4 (67) Thoracic 19 (32) 1 (17) Lumbar 21 (35) 1 (17) Sacral 9 (15) 1 (17) NA 2 (3) 1 (17) No. of tumor sites at diagnosis Single 98 (83) 41 (79) 52 (87) 5 (83) Multiple 11 (9) 4 (8) 6 (10) 1 (17) Did not know 6 (5) 5 (10) 1 (2) 0 (0) NA 3 (3) 2 (4) 1 (2) 0 (0) Abbreviations: BT, brain tumor; NA, not available; ST, spinal tumor. Tumor Information Most patients who participated in the survey had been diagnosed for several years before completing the survey (brain tumor: median, 50 months; range, months; spine tumor: median, 74 months; range months). The median age at diagnosis was 40 years (range years). Most patients had grade 2 ependymomas; however, for grade 3 (anaplastic) ependymomas, there was a strong association with brain location (chi-square statistic, ; P ¼.004). Patients with brain lesions most commonly had the tumor located infratentorially along the brainstem (52%), whereas those with spine tumors most commonly had tumors located in the cervical spine (44%). Table 2 outlines information related to diagnosis. Clinical Presentation The majority of patients had 3 symptoms before diagnosis (range, 0-10 symptoms). Common symptoms leading to diagnosis for those with brain tumors included headache (52%), visual problems (46%), nausea/vomiting (39%), weakness (33%), and numbness/tingling (33%); and 37% reported that they had symptoms for >6 months. In patients with spine tumors, numbness/tingling (58%), weakness (45%), back pain (35%), and radiating back pain (27%) were the most common symptoms; and 64% had experienced symptoms for >6 months before diagnosis. There was a significant difference in the length of time between presenting symptoms for patients who had spine tumors compared with patients who had brain tumors (chi-square statistic, 7.294; P ¼.026) Cancer November 15, 2011
5 EO Project/Armstrong et al Table 3. Treatment Course Treatment Overall BT ST BT and ST Initial surgery Biopsy 2 (2) 2 (4) 0 (0) Partial resection 19 (16) 18 (35) 1 (17) Gross total resection 35 (30) 32 (62) 3 (50) Spine surgery for biopsy 5 (4) 5 (8) 0 (0) Spine surgery with partial resection 13 (11) 13 (22) 0 (0) Spine surgery with gross total resection 37 (31) 35 (58) 2 (33) No surgery performed 2 (2) 2 (3) 0 (0) NA 5 (4) 0 5 (8) 0 (0) Condition after first surgery Better 61 (52) 34 (65) 24 (40) 3 (50) Worse 38 (32) 12 (23) 25 (42) 1 (17) Same 12 (10) 2 (4) 9 (15) 1 (17) NA 7 (6) 4 (8) 2 (3) 1 (17) Complications after first surgery Infection 12 (10) 6 (12) 4 (7) 2 (33) Blood clot 6 (5) 4 (8) 2 (3) 0 (0) Bleeding in brain 3 (3) 2 (4) 0 (0) 1 (17) Seizure 7 (6) 6 (12) 0 (0) 1 (17) Diabetes 5 (4) 2 (4) 2 (3) 1 (17) Drug allergy 6 (5) 2 (4) 3 (5) 1 (17) Weakness 45 (38) 17 (33) 24 (40) 4 (67) Paralysis 23 (20) 6 (12) 16 (27) 1 (17) Inability to urinate 10 (9) 2 (4) 7 (12) 1 (17) Incontinence 14 (12) 1 (2) 11 (18) 2 (33) Sexual dysfunction 22 (19) 5 (10) 17 (28) 0 (0) Additional treatment after surgery Radiation therapy 30 (25) 19 (37) 10 (17) 1 (17) Chemotherapy and radiation therapy 13 (11) 8 (15) 4 (7) 1 (17) Chemotherapy, radiation therapy, and radiosurgery 2 (2) 2 (4) 0 (0) 0 (0) None 64 (54) 22 (42) 38 (63) 4 (67) NA 9 (8) 1 (2) 8 (13) 0 (0) Abbreviations: BT, brain tumor; NA, not available; ST, spinal tumor. Treatment Course Most commonly, patients reported that surgery resulted in a complete resection for both brain tumors (62%) and spine tumors (58%). Patients who had spine tumors were more likely to report receiving no additional treatment after surgery compared with patients who had brain tumors (chi-square statistic, 9.687; P ¼.008). Sixty-five percent of patients with brain lesions and 40% of those with spine lesions reported improvement in their overall condition after surgery. Common complications after surgery for those with brain lesions included weakness (33%), seizures (12%), and infection (12%); whereas, for patients who underwent surgery for spine tumors, the most common postsurgical complications included weakness (40%), sexual dysfunction (28%), and incontinence (18%) (Table 3). Tumor Recurrence At the time the survey was completed, 31% of patients with brain lesions and 27% of patients with spine tumors reported having experienced a recurrence of their tumor. It is noteworthy that the majority of those with spine tumors had experienced >2 recurrences (56%), whereas most patients with brain tumors experienced only 1 recurrence (50%). The most common symptoms at recurrence included numbness or tingling in the arms, legs, or body (brain tumors, 25%; spine tumors, 50%); headache (brain tumors, 25%); and back pain (spine tumors, 44%). Most recurrences occurred in the location of the original tumor, and a variety of treatment approaches were employed, including surgery, radiation, and chemotherapy. Six percent of patients reported that they received chemotherapy alone (27% received it alone or in combination with Cancer November 15,
6 Table 4. Recurrence Information Variable Overall BT ST BT and ST Has the ependymoma recurred? No 80 (68) 35 (67) 40 (67) 5 (83) Yes 33 (28) 16 (31) 16 (27) 1 (17) NA 5 (4) 1 (2) 4 (7) 0 (0) What was the type of ependymoma at recurrence? Ependymoma 10 (30) 6 (38) 3 (19) 1 (100) Myxopapillary ependymoma 9 (27) 0 (0) 9 (56) 0 (0) Anaplastic ependymoma 7 (21) 5 (31) 2 (13) 0 (0) Did not know name 5 (15) 3 (19) 2 (13) 0 (0) NA 2 (6) 2 (13) 0 (0) 0 (0) How many times has your ependymoma recurred? 1 13 (39) 8 (50) 4 (25) 1 (100) 2 4 (12) 3 (19) 1 (6) 0 (0) >2 11 (33) 2 (13) 9 (56) 0 (0) NA 5 (15) 3 (19) 2 (13) 0 (0) Did it recur in the same location? No 7 (21) 5 (31) 2 (13) 0 (0) Yes 25 (76) 10 (63) 14 (87) 1 (100) NA 1 (3) 1 (6) 0 (0) 0 (0) Symptoms at recurrence Numbness/tingling of legs, arms, or body 13 (39) 4 (25) 8 (50) 1 (100) Headache 6 (18) 4 (25) 2 (13) 0 (0) Weakness 7 (21) 0 (0) 7 (44) 0 (0) Back pain 8 (24) 1 (6) 7 (44) 0 (0) Radiating back pain 6 (18) 0 (0) 6 (38) 0 (0) Treatment at recurrence Surgery only 8 (24) 2 (13) 6 (38) 0 (0) Radiation only 9 (27) 3 (19) 6 (38) 0 (0) Chemotherapy only 2 (6) 2 (13) 0 (0) 0 (0) Radiation and chemotherapy 1 (3) 1 (6) 0 (0) 0 (0) Surgery and radiation 4 (12) 2 (13) 1 (6) 1 (100) Surgery and chemotherapy 3 (9) 3 (19) 0 (0) 0 (0) Surgery, radiation, and chemotherapy 3 (9) 0 (0) 3 (19) 0 (0) NA 3 (9) 3 (19) 0 (0) 0 (0) Abbreviations: BT, brain tumor; NA, not available; ST, spinal tumor. radiation or surgery plus radiation), and 51% received chemotherapy with radiation therapy for tumor recurrence. Table 4 outlines these results. Follow-Up The majority of patients reported consulting a neurosurgeon for follow-up of their ependymoma (brain tumors, 35%; spine tumors, 55%), but the other patients also reported being followed with a variety of other disciplines, including family physicians or internists (see Table 5). Surprisingly, >66 separate providers, the majority of which were community-based clinics or hospitals, were listed by the 118 participants in this survey, supporting the contention that patient care is not centralized and that patients are not being treated at major academic centers. The majority of patients reported having a magnetic resonance image (MRI) to evaluate disease status on a yearly basis, and 70% had an MRI to evaluate their disease status within the last year. Fifty-three percent reported that there was no evidence of disease at the time of their last MRI. Although the survey participants reported the use of a wide variety of medications, commonly prescribed medications included anticonvulsants for those with brain tumors (21%) and narcotic analgesics for those with spine tumors (47%). Thirty percent also reported using complementary and alternative medicine therapy, including high-dose vitamins, acupuncture, and a variety of herbal preparations Cancer November 15, 2011
7 EO Project/Armstrong et al Table 5. Type of Physician Managing Patients Type of Physician Overall BT ST BT and ST Neurosurgeon 52 (44) 18 (35) 33 (55) 1 (17) Neuro-oncologist 35 (30) 19 (37) 12 (20) 4 (67) Family physician or internal medicine 21 (18) 5 (10) 16 (27) 0 (0) Radiation oncologist 18 (15) 11 (21) 6 (10) 1 (17) Oncologist 8 (7) 4 (8) 4 (7) 0 (0) Abbreviations: BT, brain tumor; ST, spinal tumor. Symptom Burden and Current Health Status The patient s current symptoms and the impact of these symptoms on daily life also were evaluated. Despite the low percentage of patients who had recurrent tumors or who were receiving active treatment, most patients described moderate-to-severe symptoms. For the group overall, the most severe general symptoms included fatigue (44%), numbness/tingling (39%), pain (36%), and disturbed sleep (34%). Patients with tumors involving the brain reported moderate-to-severe problems with vision (25%), concentration (25%), weakness (19%), irritability (19%), difficulty speaking (19%), and understanding (17%). Patients with spine ependymomas reported moderate-to-severe extremity weakness (55%), sexual dysfunction (48%), radiating pain (37%), and change in bowel pattern (35%). Participants were asked to describe their current employment and disability status in addition to current health insurance coverage. Overall, 59 patients (48%) reported that they had not been able to work since their diagnosis, and 37 patients (31%) reported that they were receiving disability benefits. The majority (53%) reported having a commercial insurance (n ¼ 62), and the next most common medical coverage was Medicare (n ¼ 32). Eighty-one percent of participants reported that they believed they had access to all the health care services that they needed (n ¼ 96), and 73% reported that their insurance was very helpful in providing payments for these services (n ¼ 86). Participants were also asked to report on their quality of life and activities. Only a few patients (n ¼ 19) reported that they were not at all content with the quality of their life and were unable to enjoy leisure pursuits (n ¼ 17). However, 26 patients (22%) reported they were unable to drive, and nearly all patients (n ¼ 98) reported that their health prevented them from participating in vigorous activities, such as running or lifting heavy objects. Seventy-two patients (61%) reported that even moderate activities (such as vacuuming) were impacted by their current health status. Participants also reported that their current health status impacted their ability to walk 1 block (n ¼ 41; 35%) or climb a flight of stairs (n ¼ 44; 37%). One-third of patients (n ¼ 33) reported that they needed assistance with bathing or dressing on a daily basis. DISCUSSION The EO Project survey was completed by approximately half of the patients who were identified as eligible for participation. It is unclear why some patients chose not to participate, and we cannot determine the impact of the responses these patients would have had on the overall survey results. The majority of patients, as expected, were diagnosed with low-grade ependymoma, and anaplastic ependymomas were much less frequent. Consistent with disease incidence, anaplastic ependymomas occur more commonly in the brain than in the spinal cord, and most patients had a solitary lesion at the time of diagnosis. A significant limitation of this study s approach, however, is that the treatment and diagnosis information provided was not validated by a review of the medical record. In addition, the length of time from diagnosis (median, 50 months) may have resulted in recall bias of self-reported presentation, treatment, and complication data. Patients reported that they experienced an average of 3 symptoms often for several months before diagnosis, and some patients reported having symptoms for several years before their diagnosis was made. It is unclear when evaluation by a health care provider was sought or whether patients were treated for other conditions in response to the patient s report of symptoms. It is noteworthy that, on average, patients who had tumors involving the spine had symptoms for a significantly longer time than patients who had Cancer November 15,
8 ependymomas involving the brain. A recent report from Kucia and colleagues also indicated a long duration of symptoms (average, 22.2 months) in a small group of patients with spinal cord ependymoma, including bowel/bladder dysfunction and weakness. 10 These data may have clinical significance, because early recognition of the diagnosis may impact therapeutic outcomes, as demonstrated in a recent report that baseline McCormick status was a predictor of postoperative neurologic dysfunction. 9 Future studies to improve earlier diagnosis should explore whether patients self-manage their symptoms or seek out evaluation in the health care system. Our survey indicated that the majority of patients underwent surgery as their only treatment. However, variations in treatment approach were identified: Twentyfive percent of patients received radiation only, and others received a variety of regimens that combined radiation and chemotherapy. These findings lend further support to the lack of standardization in treatment of these patients. Consequently, it is difficult to evaluate the impact of therapies on the ultimate clinical outcome either from the time of initial diagnosis or in patients with recurrent tumors. Although the majority of patients reported that they had not had a recurrence of their tumor, nearly 40% of patients reported that they were unable to work from the time of diagnosis and reported significant symptoms, such as pain, weakness, cognitive changes, and sexual dysfunction. In addition, the majority reported that their current health status limited their daily functions and leisure activities. There are several important implications of these findings. Ependymomas typically are considered a more benign tumor, and in this context, along with the relative rarity of the disease, the impact on patient function, ability to work, and cost of care has not been explored. The findings from this survey suggest that significant numbers of patients are impacted by their disease even when the tumor has not recurred. Nearly half of the patients with spine tumors reported needing narcotic analgesics to manage pain, and >33% had significant issues with weakness, bowel function, and sexual function. Future studies should explore the relation of symptoms to diagnosis and treatment approach and should prompt improvements in symptom management strategies. The EO Project provides a unique perspective on the presentation, clinical management, and current health status of adult patients with ependymoma from the perspective of the patient. The benefits of this analysis include sampling from a wide region rather than a single institution and the number of respondents, considering the relative rarity of the diagnosis. This information would have been difficult to obtain otherwise because of the large number and wide variety of physician specialties that are currently providing care and follow-up of these patients, as indicated by the survey. These preliminary results suggest that that the impact of this more benign tumor may be significant in terms of disability and ongoing symptomatology. Future studies are underway to further explore the treatments patients undergo as well as the economic and health impact of ependymoma in adult patients. FUNDING SOURCES This work was supported by the Collaborative Ependymoma Research Network (CERN) Foundation. CONFLICT OF INTEREST DISCLOSURES The authors made no disclosures. REFERENCES 1. Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in Hinsdale, IL: CBTRUS; Verstegen MJ, Bosch DA, Troost D. Treatment of ependymomas. Clinical and non-clinical factors influencing prognosis: a review. Br J Neurosurg. 1997;11: Armstrong TS, Vera-Bolanos E, Bekele BN, Aldape K, Gilbert MR. Adult ependymal tumors: prognosis and the M.D. Anderson Cancer Center experience. Neuro Oncol. 2010; 12: Vitanovics D, Balint K, Hanzely Z, Banczerowski P, Afra D. Ependymoma in adults: surgery, reoperation and radiotherapy for survival. Pathol Oncol Res. 2010;16: Reni M, Brandes AA. Current management and prognostic factors for adult ependymoma. Expert Rev Anticancer Ther. 2002;2: Donahue B, Steinfeld A. Intracranial ependymoma in the adult patient: successful treatment with surgery and radiotherapy. J Neurooncol. 1998;37: Shaw EG, Evans RG, Scheithauer BW, Ilstrup DM, Earle JD. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys. 1987;13: Morris K, Lye RH. Ependymoma of the fourth ventricle: an unusual presentation. Br J Neurosurg. 1988;2: Kucia EJ, Bambakidis NC, Chang SW, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas part I. Intramedullary ependymomas 5140 Cancer November 15, 2011
9 EO Project/Armstrong et al [published online ahead of print December 30, 2010]. Neurosurgery Kucia EJ, Maughan PH, Kakarla UK, Bambakidis NC, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas: part II: myxopapillary ependymoma. Neurosurgery. 2011;68(1 suppl operative):90-94; discussion Armstrong TS, Mendoza T, Gning I, et al. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006;80: Armstrong TS, Gning I, Mendoza TR, et al. Reliability and validity of the M.D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine. 2010;12: Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61: Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85: Cancer November 15,
Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team
NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN Cancer Survivorship Resources and Tools for the Multidisciplinary Team Your survivorship care plan is a summary of your tumor treatments and recommendations for
More informationClinical Utility of the MDASI-BT in Patients with Brain Metastases
Vol. 37 No. 3 March 2009 Journal of Pain and Symptom Management 331 Original Article Clinical Utility of the MDASI-BT in Patients with Brain Metastases Terri S. Armstrong, PhD, Ibrahima Gning, DrPH, Tito
More informationPatient Follow-up Form - Version 1.1
Physician: [Last Name GO PROJECT Patient Follow-up Form - Version 1.1 Thank you for participating in the Glioma Outcomes Project. To continue participating in this important project, complete or correct
More informationNON-SURGICAL STRATEGY FOR ADULT EPENDYMOMA
NON-SURGICAL STRATEGY FOR ADULT EPENDYMOMA Roberta Rudà Department of Neuro-Oncology University and City of Health and Science Hospital of Turin, Italy EORTC EANO ESMO Conference 2015 Istanbul, March 27-28
More informationNON MALIGNANT BRAIN TUMOURS Facilitator. Ros Taylor Advanced Neurosurgical Nurse Practitioner Southmead Hospital Bristol
NON MALIGNANT BRAIN TUMOURS Facilitator Ros Taylor Advanced Neurosurgical Nurse Practitioner Southmead Hospital Bristol Neurosurgery What will be covered? Meningioma Vestibular schwannoma (acoustic neuroma)
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM EPENDYMOMA Last Revision Date July 2015 1 CNS Site Group Ependymoma Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2.
More informationCHAPTER 11 Tumors Originating in the Brain Medulloblastomas, PNETs and Ependymomas
Tumors Originating in the Brain Medulloblastomas, PNETs and Ependymomas Foolishly, I waited 7 months before I joined this (or any) group. By that time, my son had radiation, chemo, and a recurrence of
More informationChildhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ )
1 di 10 27/06/2016 08.16 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute
More informationPast Surgical History
Name: DOB: Check All That Apply Past Medical History o Anemia o Aneurysm o Asthma o Bipolar o Bleeding Disorder o Blood Clot o Brain Tumor o Bronchitis o Cancer o Crohn s Disease/Ulcerative Colitis o Depression
More informationPlease complete ALL 6 pages of the form in blue/black ink. Patient Acct # Provider # BMI # Height Weight
Please complete ALL 6 pages of the form in blue/black ink. Patient Acct # Provider # BMI # Height Weight f-25-n (08-07-13) ( 11-02-12) 0 10 Spine Questionnaire (continued) OFFICE USE ONLY Patient Acct
More informationDear Patient, Sincerely, South Texas Bone & Joint Physical Therapy & Rehabilitation Team
Physical Therapy & Rehabilitation 601 Texan Trail, Suite 250 Corpus Christi, Texas 78411 Telephone: (361)854-0811 EXT 221 Fax: (361)561-0609 www.southtexasboneandjoint.com Dear Patient, South Texas Bone
More informationPatient Registration
Acct #: Patient Registration Section I Patient Information Date Last First: M.I. I prefer to be called: Mailing Address: City: State: Zip Home Phone Cell Phone Work Phone Email: Employer: Date of Birth:
More informationFeasibility Trial of Optune for Children with Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma
Feasibility Trial of Optune for Children with Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma ABSTRACT Recurrent or progressive pediatric CNS tumors generally have a poor prognosis
More informationChika Nwachukwu, Ph.D. MS IV Radiation Oncology Rotation
Chika Nwachukwu, Ph.D. MS IV Radiation Oncology Rotation Background Histology/Tumor Characteristics Presenting Symptoms/diagnosis Treatment/outcome Patient cohort Research on HRQOL Slow growing indolent
More informationBACK AND NECK PAIN QUESTIONNAIRE
Neurological Surgery and Spine Surgery, S.C. 1 Westbrook Corporate Center, Suite 800 Westchester, Illinois 60154 BACK AND NECK PAIN QUESTIONNAIRE Please PRINT all information CLEARLY and answer all questions
More informationGood. Poor [ ] [ ] Yes, at all [ A ] Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf [ ] [ ]
PATIENT I.D. This survey asks for your views about your health. This information will help keep track of how you feel and how well you are able to do your usual activities. For each of the following questions,
More informationBrain tumors: tumor types
Brain tumors: tumor types Tumor types There are more than 120 types of brain tumors. Today, most medical institutions use the World Health Organization (WHO) classification system to identify brain tumors.
More informationAuthor Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce
Survey of disease and treatment-related t t related symptoms in outpatients with invasive i cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study, Abst # 9619) Michael J. Fisch,
More informationEpendymomas: Prognostic Factors and Outcome Analysis in a Retrospective Series of 33 Patients
ORIGINAL ARTICLE Brain Tumor Res Treat 2017;5(2):70-76 / pissn 2288-2405 / eissn 2288-2413 https://doi.org/10.14791/btrt.2017.5.2.70 Ependymomas: Prognostic Factors and Outcome Analysis in a Retrospective
More informationFOCUSING ON TUMORS. Ependymoma
FOCUSING ON TUMORS Ependymoma A Word About ABTA Founded in 1973, the not-for-profit American Brain Tumor Association has a proud history of funding research, providing patient services, and educating people
More informationUpdate on Pediatric Brain Tumors
Update on Pediatric Brain Tumors David I. Sandberg, M.D. Director of Pediatric Neurosurgery & Associate Professor Dr. Marnie Rose Professorship in Pediatric Neurosurgery Pre-talk Questions for Audience
More informationPatient Name: Date of Birth:
Patient Name: Date of Birth: Marital Status: Single Married Divorced Widowed Height: Referring Doctor: Weight: Primary Care Dr.: Preferred Pharmacy:(name/address) ALLERGIES: Do you have any drug allergies?
More informationTHE EFFECTIVE OF BRAIN CANCER AND XAY BETWEEN THEORY AND IMPLEMENTATION. Mustafa Rashid Issa
THE EFFECTIVE OF BRAIN CANCER AND XAY BETWEEN THEORY AND IMPLEMENTATION Mustafa Rashid Issa ABSTRACT: Illustrate malignant tumors that form either in the brain or in the nerves originating in the brain.
More informationChapter V Depression and Women with Spinal Cord Injury
1 Chapter V Depression and Women with Spinal Cord Injury L ike all women with disabilities, women with spinal cord injury (SCI) may be at an elevated risk for depression due to the double jeopardy of being
More informationChildhood Brain and Spinal Cord Tumors Treatment Overview (PDQ )
1 di 14 27/11/2016 17.42 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute
More informationASJ. Myxopapillary Ependymoma of the Cauda Equina in a 5-Year-Old Boy. Asian Spine Journal. Introduction
Asian Spine Journal 846 Masashi Case Uehara Report et al. Asian Spine J 2014;8(6):846-851 http://dx.doi.org/10.4184/asj.2014.8.6.846 Asian Spine J 2014;8(6):846-851 Myxopapillary Ependymoma of the Cauda
More informationThe Value of a Chest CT in the Evaluation of a Newly Detected Brain Tumor
Southern Adventist Univeristy KnowledgeExchange@Southern Senior Research Projects Southern Scholars 1999 The Value of a Chest CT in the Evaluation of a Newly Detected Brain Tumor Jennifer L. White John
More informationNew Patient Intake Forms. Patient Data Date. Title: (Check one) Mr. Mrs. Ms. Miss Dr. Other. First Name Middle Initial Last Name
New Patient Intake Forms Patient Data Date Title: (Check one) Mr. Mrs. Ms. Miss Dr. Other First Name Middle Initial Last Name I prefer to be called by Address Line City State Zip Code Home Phone ( ) -
More informationCascadia Chiropractic Centre
Name: Cascadia Chiropractic Centre New Patient Information & Clinical Record Date: Date of Birth: Your age: Care Card #: Address: City/Prov: Postal Code: Phone: Cell: Work Phone: E-mail Address: Marital
More informationSpinal myxopapillary ependymoma with interval drop metastasis presenting as cauda equina syndrome: case report and review of literature
Case Report Spinal myxopapillary ependymoma with interval drop metastasis presenting as cauda equina syndrome: case report and review of literature Shrikant V. Rege, Sharadendu Narayan, Harshad Patil,
More informationNew Practice Member Paperwork
Cornerstone Family Chiropractic Health Information Form 928.237.9477 www.cfc4familyhealth.com 2225 E State Route 69 Suite A Prescott, AZ 86301 New Practice Member Paperwork This form is for adults only.
More informationPlease review the below items in preparation for your visit.
2001 Santa Monica Blvd., Suite #760W Santa Monica, CA 90404 (310) 582-7474 (Office) (310) 582-7481 (Fax) http://california.providence.org/saint-johns/services/orthopedics/ http://www.totaljoints.net/ Dear
More informationSPINE PROGRAM NEW PATIENT FORM
Name: Date of Birth: Today s Date: Are you right or left handed? What are your goals for the visit? Who referred you to us? Primary Doctor Another Doctor Dr. Of what specialty? Someone else: PAIN 1. Tell
More informationPediatric Brain Tumors: Updates in Treatment and Care
Pediatric Brain Tumors: Updates in Treatment and Care Writer Classroom Rishi R. Lulla, MD MS Objectives Introduce the common pediatric brain tumors Discuss current treatment strategies for pediatric brain
More informationMALIGNANT GLIOMAS: TREATMENT AND CHALLENGES
MALIGNANT GLIOMAS: TREATMENT AND CHALLENGES DISCLOSURE No conflicts of interest to disclose Patricia Bruns APRN, CNS Givens Brain Tumor Center Abbott Northwestern Hospital October 12, 2018 OBJECTIVES THEN
More informationHEALTH INFORMATION FORM
#102, 506-71 Ave SW Calgary AB T2V 4V4 Ph 587.352.9199 Fax 1.888.501.1724 info@fullcirclecalgary.ca www.fullcirclecalgary.ca Part 1: BASIC INFORMATION HEALTH INFORMATION FORM Name: Date: Address: City:
More informationWho may we thank for referring you? Office Only LIST YOUR HEALTH CONCERNS BELOW. If you had the condition before, when? When did this episode start?
Name Date / / Age Male / Female Address City State Zip Phone: Home Cell Cell Phone Provider Date of Birth / / Email Address Occupation Employer s Name Single / Married / Divorced / Widowed Spouse s Name
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM ANAPLASTIC GLIOMAS CNS Site Group Anaplastic Gliomas Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationNEW PATIENT QUESTIONNAIRE Spine pt acct #
NEW PATIENT QUESTIONNAIRE Spine pt acct # Name: Date of Visit: Male Female (please fill in the circles) Date of Birth: Height: Weight: Age Today: What studies have been done on your spine? Where/When?
More informationChildhood Craniopharyngioma Treatment (PDQ )
1 di 12 27/06/2016 09.45 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute
More informationNew Practice Member Application
New Practice Member Application Name Date of Birth / / Age Male/Female Address City State Zip Phone: Cell Home Social Security #: Email: Occupation Employer s Name Status: Single / Married / Divorced /
More informationSystemic Treatment. Third International Neuro-Oncology Course. 23 May 2014
Low-Grade Astrocytoma of the CNS: Systemic Treatment Third International Neuro-Oncology Course São Paulo, Brazil 23 May 2014 John de Groot, MD Associate Professor, Neuro-Oncology UT MD Anderson Cancer
More informationBACKGROUND HISTORY QUESTIONNAIRE
BACKGROUND HISTORY QUESTIONNAIRE Name: Sex M F Address: Home Number: Work Number: Cell Number: Email: SSN: Name and Address of Employer: Date of Birth: Age: Ethnicity: Referred By: Referral Question or
More informationASJ. Surgical Outcomes of High-Grade Spinal Cord Gliomas. Asian Spine Journal. Introduction
Asian Spine Journal Asian Spine Clinical Journal Study Asian Surgical Spine J 2015;9(6):935-941 outcomes of high-grade http://dx.doi.org/10.4184/asj.2015.9.6.935 intramedullary tumor 935 Surgical Outcomes
More informationPatient Intake Assessment Tools for Navigation
Patient Intake Assessment Tools for Navigation Review and utilize the following with new patient referrals to the Navigation program: Psychosocial Distress Screening Tool : Commission on Cancer Standard
More informationKEYWORDS: symptoms, symptom assessment, cancer, symptom management, M. D. Anderson Symptom Inventory, MDASI.
The Symptom Burden of Cancer: Evidence for a Core Set of Cancer-Related and Treatment-Related Symptoms From the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns Study Charles S.
More informationNAME OF PATIENT: STREET ADDRESS: CITY: STATE: ZIP: SEX: Male Female AGE: BIRTHDATE: MARITAL STATUS: PATIENT EMPLOYED BY: BUSINESS ADDRESS:
DATE: HOME PHONE: NAME OF PATIENT: (Last name) (First name) (Middle) RESPONSIBLE PARTY (if a minor): STREET ADDRESS: CITY: STATE: ZIP: SEX: Male Female AGE: BIRTHDATE: MARITAL STATUS: PATIENT EMPLOYED
More informationPatient Name: Date: Address: Primary Care Physician: Online Website On TV In print On the radio
927 W. Myrtle St. Boise, ID 83702 (208) 947-0100 NEW PATIENT INTAKE Patient Name: Date: Email Address: Primary Care Physician: How did you hear about AVT? (Please mark all that apply) Online Website On
More informationOligodendrogliomas & Oligoastrocytomas
Oligodendrogliomas & Oligoastrocytomas ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit organization dedicated solely
More informationHome Address. City Postal Code Home Telephone # Business Telephone # Address. Emergency Contact Name, Address, Phone#
Date Name / / last first middle initial Personal Health # - Male Female Home Address City Postal Code Home Telephone # Business Telephone # Cell # E-Mail Address Best way to contact you: Home # Work #
More informationRAINIER VALLEY CHIROPRACTIC P.S th Avenue S. Seattle, WA 98118
Patient Health History Full Name Date Street Address City & State Zip Phone Number Gender Date of Birth Age SSN How did you hear about our office? Marital Status # of Children? Currently Pregnant? / How
More informationAMERICAN BRAIN TUMOR ASSOCIATION. Oligodendroglioma and Oligoastrocytoma
AMERICAN BRAIN TUMOR ASSOCIATION Oligodendroglioma and Oligoastrocytoma ACKNOWLEDGEMENTS ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION Founded in 1973, the American Brain Tumor Association (ABTA) was the
More informationAdult New Patient Intake. Your Health Summary
Adult New Patient Intake Name Age Birth Date / / Soc. Sec. # - - Home Phone Cell Phone Address: City: State: Zip: Occupation: Email Marital Status: M W D S Spouse s Name: Children # and Ages: Whom may
More informationBrain and Central Nervous System Cancers
Brain and Central Nervous System Cancers NICE guidance link: https://www.nice.org.uk/guidance/ta121 Clinical presentation of brain tumours History and Examination Consider immediate referral Management
More information3/5/2018 CANCER ASSOCIATED FATIGUE & PAIN OBJECTIVES CHRONIC PAIN ACUTE PAIN PAIN SCALES
OBJECTIVES CANCER ASSOCIATED FATIGUE & PAIN SCOT M. SAWYER, PT, DPT BOARD CERTIFIED ELECTROPHYSIOLOGY CLINICAL SPECIALIST EMAIL: SAWYER@CAMPBELL.EDU Recognize the multi-factorial pain response cancer survivors
More informationAdult intramedullary astrocytomas of the spinal cord
J Neurosurg 77:355-359, 1992 Adult intramedullary astrocytomas of the spinal cord FRED J. EPSTEIN, M.D., JEAN-PIERRE FARMER, M.D., F.R.C.S., AND DIANA FREED Division of Pediatric Neurosurgery, Department
More informationPrior to 1993, the only data available in the medical
Neuro-Oncology Prospective clinical trials of intracranial low-grade glioma in adults and children Edward G. Shaw 1 and Jeffrey H. Wisoff Department of Radiation Oncology, Wake Forest University School
More informationHealth-Related Quality of Life in Brain Tumor Patients Treated with Surgery: Preliminary Result of a Single Institution
ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(2):87-93 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.2.87 Health-Related Quality of Life in Brain Tumor Patients Treated with
More informationPatient Medical Information. Last. Sex: M / F Age: Date of Birth: Home Address: City: State: Zip Code: Business Address: City: State: Zip Code:
Patient Medical Information Name: First Middle Last Sex: M / F Age: Date of Birth: Social Security # Driver s License # Home Address: City: State: Zip Code: Home Phone: Occupation: Cell: Employer: Business
More informationPATIENT ENTRANCE FORM
PATIENT ENTRANCE FORM Name _ Date Address City/ Province Postal Code Home Telephone Work Telephone Email Address Would like email reminders for appointments? Yes No Date of Birth (Day/Month/Year) Age Marital
More informationPain Management Questionnaire
In order to make the most of your visit, we require this form to be completed to the best of your ability and sent to the Pain Management Clinic a copy should be shared with your Primary Care Provider
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation
More informationMedical History Questionnaire
Date Medical History Questionnaire Name DOB Reason for visit When did symptoms first appear Is the condition getting worse? Please rate your pain 0 1 2 3 4 5 6 7 8 9 10 No Pain Extreme Pain Please circle
More informationWho may we thank for referring you?
NEW PRACTICE MEMBER APPLICATION Name Date of Birth / / Age Male/Female Address City State Zip Phone: Cell Home Social Security #: Email: Occupation Employer s Name Status: Single / Married / Divorced /
More informationAdult Brain and Spinal Cord Tumors
Adult Brain and Spinal Cord Tumors An adult central nervous system (CNS) tumor is a disease in which abnormal cells form in the tissues of the brain and or the spinal cord. Major Parts of the Brain Anatomy
More informationSmall and Big Operations: New Tools of the Trade for Brain Tumors. Disclosure. Incidence of Childhood Cancer
Small and Big Operations: New Tools of the Trade for Brain Tumors Nalin Gupta MD PhD Chief, Division of Pediatric Neurosurgery Departments of Neurosurgery and Pediatrics University of California San Francisco
More informationThe use of surgery in the elderly. for management of metastatic epidural spinal cord compression
The use of surgery in the elderly Bone Tumor Simulators for management of metastatic epidural spinal cord compression Justin E. Bird, M.D. Assistant Professor Orthopaedic Oncology and Spine Surgery Epidemiology
More informationWhat is your present motivation for consulting our office? Vital Information (Adult)
What is your present motivation for consulting our office? Heal disease, symptoms and infirmities (ill-health) Preventing disease, symptoms and infirmities (ill-health) Improving family and/or community
More informationNUMBNESS EVALUATION FORM Date: Name: Last First Initial Date of Birth SS # - - Age: Dominant Hand: Right Left Height: Weight:
NUMBNESS EVALUATION FORM Date: Name: Last First Initial Date of Birth SS # - - Age: Dominant Hand: Right Left Height: Weight: I Referring Doctor Complete Name of Referring Doctor Last Complete Address
More informationQuality of Life After Modern Treatment Options for Prostate Cancer Ronald Chen, MD, MPH
Quality of Life After Modern Treatment Options I will be presenting some recently published data on the quality of life after modern treatment options for prostate cancer. My name is Dr. Ronald Chen. I'm
More informationOncologic Emergencies: When to call the Radiation Oncologist
Oncologic Emergencies: When to call the Radiation Oncologist Dr. Shrinivas Rathod Radiation Oncologist Radiation Oncology Program CancerCare Manitoba and University of Manitoba Disclosures Speaker s name:
More informationEpendymoma Programme Synopsis
Ependymoma Programme Synopsis TITLE SPONSOR PROTOCOL NUMBER EUDRACT NUMBER NATIONAL INVESTIGATOR- COORDINATOR SIOP Ependymoma program II: An International Clinical Program for the diagnosis and treatment
More informationNEW PATIENT INFORMATION FORM
NEW PATIENT INFORMATION FORM Name: LAST FIRST MIDDLE Date of Birth: Sex: Marital Status: SS Number: Address: City: State: Zip Phone: Home Cell Work Email: Communication Preference: Patient Portal Phone
More informationDEPARTMENT OF NEUROSURGERY Spine Center New Patient Intake Form
DEPARTMENT OF NEUROSURGERY Spine Center New Patient Intake Form Today's date: Your name: Date of birth: Email address: CHIEF COMPLAINT What is the main reason that you are seeking medical attention? Please
More informationThe effect of early versus delayed radiation therapy on length of hospital stay in the palliative setting
Original Article on Palliative Radiotherapy The effect of early versus delayed radiation therapy on length of hospital stay in the palliative setting Taylor R. Cushman 1, Shervin Shirvani 2, Mohamed Khan
More informationNAME: DATE: SPINE CENTER NEW PATIENT QUESTIONNAIRE
Please complete and give to the receptionist when you arrive at the office for your appointment. NAME: DATE: SPINE CENTER NEW PATIENT QUESTIONNAIRE Page 1 of 6 Primary Care Physician s Name Primary Care
More informationPatient information. Today s Date. Patient s Name D.O.B. Street Address Apt. No. Home Phone # Work Phone # Social Security # DL # State
Patient information Today s Date Patient s Name D.O.B Street Address Apt. No. City / State / Zip Code Home Phone # Work Phone # Social Security # DL # State Sex Female Male Marital Status Single Married
More informationTake control of your pain therapy. Getting started with Algovita SCS.
Take control of your pain therapy. Getting started with Algovita SCS. The two-step approach to spinal cord stimulation therapy. You ve talked with your doctor. You ve discussed it with your family. You
More informationIntegrating Pain Metrics into Oncologic Clinical and Regulatory Decision-Making. Charles Cleeland MD Anderson Cancer Center
Integrating Pain Metrics into Oncologic Clinical and Regulatory Decision-Making Charles Cleeland MD Anderson Cancer Center Panelists Charles Cleeland, Department Chair, Department of Symptom Research,
More informationWelcome to Compass Chiropractic!
Welcome to Compass Chiropractic! Name Age Birth Date / / Home Phone: Cell Phone: Preferred Number: Cell / Home Address: City: State: Zip: Occupation: Email Marital Status: M W D S P Spouse s Name: Number
More informationCHRONIC PAIN EVALUATION. Please help us understand your pain by completing this drawing:
JOSE G. VELIZ MD, INC. Diplomate of the American Board of Interventional Pain Management Diplomate of the American Board of Anesthesiology Diplomate of the American Board of Pain Medicine Fellow of Interventional
More informationABOUT YOU (Please print clearly) Name Birth Date Age Sex: Male Female Referring MD Mailing Address: Address
ABOUT YOU (Please print clearly) Name Birth Date Age Sex: Male Female Referring MD Mailing Address: Address Home phone number MD Phone number Work number Any other MD you request we send information to?
More informationMEDICAL HISTORY FORM
MEDICAL HISTORY FORM Patient Name: Date of Birth: Date: Email: Address: Emergency Contact (name, relationship to patient, & phone): Height: Weight: Right/Left Hand Dominant: [ ] Male [ ] Female What area
More informationArizona Injury Medical Associates, P.L.L.C. Physiatry Care
GENERAL INFORMATION HISTORY QUESTIONNAIRE Name: Today s Date: Age: Date of birth: Sex: M F SS#: Home Address: Cell Phone: Your doctor: Home Phone: Your Attorney (if any): If questions arise after today
More informationCHIROPRACTIC NEW PATIENT FORM REASON FOR VISIT
DR. ANN IZARD, B.COMM, DC DOCTOR OF CHIROPRACTIC 4353 HASTINGS STREET BURNABY, BC V5C 2J7 TEL: 604.293.2941 FAX: 604.298.2941 WWW.BHIHC.COM WWW.ANNIZARD.COM FULL NAME: DATE OF BIRTH (DD/MM/YYYY): STREET
More informationWorkers Compensation Questionnaire. Name: Address: Telephone: City: State: Zip: Social Security Number: Cell Phone: Home phone: Work Phone:
Workers Compensation Questionnaire Name: Address: Telephone: City: State: Zip: Social Security Number: Email: Cell Phone: Home phone: Work Phone: Date of birth Sex: Male Female Marital States S M D W Date
More informationBreast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity
Breast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity WORKING GROUP: This report will be written within the Cancer Control Working Group with oversight from the Second Malignant
More informationR Number. Patient Intake
Date: dd/mm/yy Patient Information Name: OHIP #: Female Male Age: Date of Birth: dd/mm/yy Phone: Address: Email: City: Postal Code: What is your current marital status? Married Common-law Single (never
More informationNew Patient Pain Evaluation
New Patient Pain Evaluation Name: Date: Using the following symbols, mark the areas of the body diagrams which are affected by your pain: \\ = Stabbing * = Electrical X = Aching N = Numbness 0 = Dull S
More informationPAIN TREATMENT CENTER
PAIN TREATMENT CENTER Name Date Age Occupation Referring Doctor Have you ever been a patient of a Pain Clinic or Center? Yes No If yes where: When did you first notice symptoms of your pain problem? Date
More information634 N. STATE STREET, WESTERVILLE OH, (614) 901-WELL
eas 634 N. STATE STREET, WESTERVILLE OH, 43082 (614) 901-WELL www.abilitychiro.com Name: Age: Date: Address: City: State: Zip Code: Alternate Address: City: State: Zip Code: Cell Phone: ( ) Cell Phone
More informationPhysical Evidence Chiropractic 7035 Beracasa Way, Suite 103 Boca Raton Florida, Phone# (561) Fax# (561)
7035 Beracasa Way, Suite 103 Boca Raton Florida, 33433 Phone# (561)674-1217 Fax# (561)361-4999 Date File # PERSONAL HISTORY Last Name First Name middle Address City State Zip Date of Birth Age Social Security
More informationSelecting the Optimal Treatment for Brain Metastases
Selecting the Optimal Treatment for Brain Metastases Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Understand the benefits, limitations,
More informationCORNERSTONE PAIN MANAGEMENT
SECONDARY INSURANCE PRIMARY INSURANCE CORNERSTONE PAIN MANAGEMENT PATIENT INFORMATION First Name: Dr. Mr. Mrs. Ms. Miss MI: Last Name: Social Security: Age: Date of Birth: Gender: Address: City: State:
More informationVisit us at
1 611 Northern Boulevard, Great Neck, NY 11021 Phone 516-570-4400 or 844-566-3876 Fax 516-570-4444 INSTRUCTIONS: PLEASE FILL OUT ENTIRE QUESTIONNAIRE AND RETURN TO THE CHIARI INSTITUTE WITH A COPY OF YOUR
More informationAMERICAN BRAIN TUMOR ASSOCIATION. Oligodendroglioma and Oligoastrocytoma
AMERICAN BRAIN TUMOR ASSOCIATION Oligodendroglioma and Oligoastrocytoma ACKNOWLEDGEMENTS ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION Founded in 1973, the American Brain Tumor Association (ABTA) was the
More informationThe Advanced Spine Center Jason E. Lowenstein, MD Jamie L. DiGraziano, PA-C
The Advanced Spine Center Jason E. Lowenstein, MD Jamie L. DiGraziano, PA-C ADULT SPINE HISTORY For Office Use Only: HR: BP: / Name of Patient: Date: Date of Birth: Age: Height: ft in Weight: lbs Form
More informationAdult Central Nervous System Tumors Treatment (PDQ )
1 di 20 28/06/2016 11.18 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute
More informationSamuel A. Joseph, Jr., M.D. In order to be seen by one of our physicians, you must bring the following to your visit:
Samuel A. Joseph, Jr., M.D. Your appointment has been scheduled: Your appointment time is: Please arrive at: o o o 2727 West Dr. Martin Luther King Jr. Blvd. Suite 590 Tampa, FL 33607 1840 Mease Drive
More information